North Africa vs Tanzania, United Republic of: New HIV infections
North Africa
1,300
in 2009
Tanzania, United Republic of
100,000
in 2009
North Africa rank
6th
Tanzania, United Republic of rank
6th
New HIV infections over time
- North Africa
- Tanzania, United Republic of
How they compare
Tanzania, United Republic of currently reports 100,000 against 1,300 in North Africa, a difference of 98,700.
That makes Tanzania, United Republic of's figure about 76.9 times North Africa's.
Across all 20 years both countries report, Tanzania, United Republic of has been ahead every year.
North Africa ranks 6th and Tanzania, United Republic of ranks 6th of 6 groups.
Tanzania, United Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Africa | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1,310 | 158,000 | 156,690 | Tanzania, United Republic of |
| 2000s | 1,270 | 124,000 | 122,730 | Tanzania, United Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new hiv infections, North Africa or Tanzania, United Republic of?
- Tanzania, United Republic of, at 100,000 against 1,300 in North Africa as of 2009.
- What is the difference in new hiv infections between North Africa and Tanzania, United Republic of?
- 98,700, with Tanzania, United Republic of ahead.
- How many years of comparable data are there for North Africa and Tanzania, United Republic of?
- 20 years are reported by both, from 1990 to 2009.
- How do North Africa and Tanzania, United Republic of rank globally for new hiv infections?
- North Africa ranks 6th and Tanzania, United Republic of ranks 6th of 6 groups.
- Where does this data come from?
- UNAIDS and the WHO's Report on the Global AIDS Epidemic, published as New HIV infections. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of people newly infected with HIV.